First Hawaiian Q3 Revenue Expected to Rise; Analysts Adjust Ratings Ahead of Report
First Hawaiian, Inc. is set to release its third-quarter earnings before the market opens on October 23. Analysts expect the Honolulu, Hawaii-based company to report quarterly earnings per…
First Hawaiian, Inc. is set to release its third-quarter earnings before the market opens on October 23.
Analysts expect the Honolulu, Hawaii-based company to report quarterly earnings per share of 59 cents, flat with the 59 cents reported in the same period last year. The market consensus for FHB's quarterly revenue stands at $228.92 million, compared to the $226.39 million reported last year.
On July 24, First Hawaiian reported second-quarter results that beat expectations.
First Hawaiian shares rose 3.2% on Thursday, closing at $26.13. Readers can access the latest analyst ratings on the analyst stock ratings page, filterable by ticker symbol, company name, analyst firm, rating change, or other variables.
Let's take a look at how the most accurate analysts recently rated the company.
TD Cowen analyst Janet Lee maintained a "Hold" rating on October 5, 2026, and lowered the price target from $31 to $28. The analyst has an accuracy rate of 54%.
JPMorgan analyst Anthony Elian upgraded the stock from "Underweight" to "Neutral" on October 1, 2026, and lowered the price target from $30 to $29. The analyst has an accuracy rate of 52%.
Piper Sandler analyst Matthew Clark maintained a "Neutral" rating on October 1, 2026, and lowered the price target from $30 to $27. The analyst has an accuracy rate of 70%.
Stephens & Co. analyst Andrew Terrell maintained an "Equal Weight" rating on the stock on July 29, 2026, and raised the price target from $28 to $32. The analyst has an accuracy rate of 67%.
Benchmark analyst Andrew Liesch initiated coverage on the stock with a "Hold" rating on July 9, 2026. The analyst has an accuracy rate of 70%.
Considering buying FHB stock? Here's what analysts think.
insigtX content is informational and educational, not investment advice.